Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Daily Adaptive RadioTherapy in Postoperative HypofrActionated Salvage radiothERapy for Prostate Cancer Patients

NCT05884632 is registered in ClinicalTrials.gov with IRCCS Sacro Cuore Don Calabria di Negrar as lead sponsor.

NCT NCT05884632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05884632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Daily Adaptive RadioTherapy in Postoperative HypofrActionated Salvage radiothERapy for Prostate Cancer Patients
Lead sponsor
IRCCS Sacro Cuore Don Calabria di Negrar
Phase
Not applicable
Overall status
Recruiting
Start date
April 3, 2023
Completion date
April 30, 2030
Enrollment
184 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer